Submissions from 2023
Feasibility of intraoperative injection of radioactive tracer and blue dye for sentinel lymph node biopsy in vulvar cancer., Alison A Garrett, Jason Ricciuti, Susan M Lang, Mary E Burriss, Margaret Flanigan, Emily O'Brien, Casey Hay, Jamie Lesnock, Jessica L Berger, and Sarah E Taylor
13. Long-term efficacy, safety and predictors of response to amivantamab among patients with post-platinum EGFR exon 20 insert (Ex20ins)-mutated advanced non-small cell lung cancer (aNSCLC) — CHRYSALIS (NCT02609776), P Garrido, Rachel E Sanborn, and See full list of authors in comments
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study., Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber, Minh D Dao, Emese Zsiros, Renata R Urban, Heidi J Gray, Barbara A Goff, Chirag A Shah, Nikki L Neubauer, James Y Dai, Janos L Tanyi, and John B Liao
Precise tumor & patient selection for CDR404: A bispecific & bivalent MAGE-A4 T cell engager, G Giacomazzi, Rom Leidner, and See full list of authors in comments
The presence of targetable mutations in metastatic non-small cell lung cancer patients with malignant pleural disease is not associated with improved survival The American Thoracic Society Washington, DC, CR Gilbert, Candice L. Wilshire, and See all authors in comments
Mammogram perceptions, communication, and gaps in care among individuals with non-English language preference in Oregon and Washington states., Monique Gill, Hannah Cohen-Cline, Megan Holtorf, and Keri Vartanian
Risk factors for venous thromboembolism (VTE) among patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) receiving amivantamab plus lazertinib versus either agent alone, N Girard, Rachel Sanborn, and See all authors in comments
Characterization of Lymph Node Tumor Burden in Node-Positive Prostate Cancer Patients after Robotic-Assisted Radical Prostatectomy with Extended Pelvic Lymph Node Dissection., Josh Gottlieb, Shu-Ching Chang, Jane Choe, Gary Grunkemeier, Douglas Hanes, David L Krasne, Dave S B Hoon, and Timothy G Wilson
Predictors of Intraoperative Difficulty and Postoperative Examination Abnormalities in 164 Orbital Operations., Akshay Govind, Shaban Demirel, Kristin Lee, Melissa Amundson, Richard Bryan Bell, and Eric Dierks
Pap smear recommendations in older women, does the data support stopping?, Emma Grabinski and Rebecca Dunsmoor-Su
“Impact of Her2 Low on Survival in Patients Treated with Standard Therapies in Advanced Breast Cancer”, SL Graff, Bansal Rani, Adeyelu Tolulope, Elliott Andrew, Walker Phillip, MA Bustos, Rodriguez Estelamari, and See full list of authors in comments
Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer., Stephanie L Graff, Fengting Yan, and Yara Abdou
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing., Heidi J Gray, Payel Chatterjee, Rachele Rosati, Lauren R Appleyard, Grace J Durenberger, Robert L Diaz, Hallie A Swan, Danielle Peretti, Maddy Pollastro, Trevor Ainge, Katannya Kapeli, Shalini Pereira, Astrid L Margossian, Kalyan Banda, Barbara A Goff, Elizabeth M Swisher, Brady Bernard, Christopher J Kemp, and Carla Grandori
Evidence-based procedures to improve the reliability of circulating miRNA biomarker assays., Sarah R Greytak, Kelly B Engel, Dave S B Hoon, Kevin M Elias, Christina M Lockwood, Ping Guan, and Helen M Moore
HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck Pathology., Ruta Gupta, Munita Bal, Justin A Bishop, Keith D Hunter, Kelly Magliocca, Raja R Seethala, Lester D R Thompson, Ilan Weinreb, Peter Angelos, Beth Beadle, R Bryan Bell, Jonathan R Clark, Robert Ferris, Shao Hui Huang, D Neil Hayes, Rahul Ladwa, Jean Yang, Nicole A Cipriani, Brenda L Nelson, Peter M Sadow, and James S Lewis
A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors., Ankit Halder, Deeptarup Biswas, Aparna Chauhan, Adrita Saha, Shreeman Auromahima, Deeksha Yadav, Mehar Un Nissa, Gayatri Iyer, Shashwati Parihari, Gautam Sharma, Sridhar Epari, Prakash Shetty, Aliasgar Moiyadi, Graham Roy Ball, and Sanjeeva Srivastava
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy., Thorvardur R Halfdanarson, Nadine Mallak, Scott Paulson, Chandrikha Chandrasekharan, Mona Natwa, Ayse Tuba Kendi, and Hagen F Kennecke
Sentinel lymphatic mapping for gynecologic malignancies., Anjali Y Hari and Krishnansu S Tewari
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma., Jessica C Hassel, Sophie Piperno-Neumann, Piotr Rutkowski, Jean-Francois Baurain, Max Schlaak, Marcus O Butler, Ryan J Sullivan, Reinhard Dummer, John M Kirkwood, Marlana Orloff, Joseph J Sacco, Sebastian Ochsenreither, Anthony M Joshua, Lauris Gastaud, Brendan Curti, Josep M Piulats, April K S Salama, Alexander N Shoushtari, Lev Demidov, Mohammed Milhem, Bartosz Chmielowski, Kevin B Kim, Richard D Carvajal, Omid Hamid, Laura Collins, Koustubh Ranade, Chris Holland, Constance Pfeiffer, and Paul Nathan
An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer., James R Heath, Daniel Chen, Jingyi Xie, Jongchan Choi, Rachel H Ng, Rongyu Zhang, Sarah Li, Rick Edmark, Hong Zheng, Benjamin Solomon, Katie Campbell, Egmidio Medina, Antoni Ribas, Purvesh Khatri, Lewis Lanier, Philip Mease, Jason D Goldman, and Yapeng Su
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer., Thomas J Herzog, Sandro Pignata, Sharad A Ghamande, Maria-Jesús Rubio, Keiichi Fujiwara, Christof Vulsteke, Deborah K Armstrong, Jalid Sehouli, Robert L Coleman, Hani Gabra, Giovanni Scambia, Bradley J Monk, José A Arranz, Kimio Ushijima, Rabbie Hanna, Claudio Zamagni, Robert M Wenham, Antionio González-Martín, Brian Slomovitz, Yan Jia, Lisa Ramsay, Krishnansu S Tewari, Susan C Weil, and Ignace B Vergote
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants., Daniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl, Mathieu Gigoux, David Schröder, Andrew Chow, Jacob M Ricca, Billel Gasmi, Olivier De Henau, Levi Mark B Mangarin, Yanyun Li, Linda Hamadene, Anne-Laure Flamar, Hyejin Choi, Czrina A Cortez, Cailian Liu, Aliya Holland, Sara Schad, Isabell Schulze, Allison Betof Warner, Travis J Hollmann, Arshi Arora, Katherine S Panageas, Gabrielle A Rizzuto, Rebekka Duhen, Andrew D Weinberg, Christine N Spencer, David Ng, Xue-Yan He, Jean Albrengues, David Redmond, Mikala Egeblad, Jedd D Wolchok, and Taha Merghoub
T cell immunotherapies recruit and activate neutrophils to eliminate tumor antigen escape variants, D Hirschorn, AD Weinberg, and See full list of authors in comments
Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study, AL Ho, Rom Leidner, and See full list of authors in comments
Monitoring 1q21.3 amplification in circulating tumor DNA from metastatic melanoma patients receiving immune checkpoint inhibitor therapies, DSB Hoon, SY Lin, Y Kobayashi, X Zhang, Q Yu, S O’Day, and MA Bustos
“UBQLN4 triggers MRE11a and STING proteasomal degradation during cisplatin-induced DNA damage response in solid tumors, DSB Hoon, Y Shiloh, T Murakami, Y Kobayashi, R Jachimowicz, and MA Bustos
Mouse Models for Sarcoma Research: NEAT1 Promotes Sarcoma Metastasis, J Huang
Organotypic Models for Functional Drug Testing of Human Cancers., Yu Ling Huang, Lindsay K Dickerson, Heidi Kenerson, Xiuyun Jiang, Venu Pillarisetty, Qiang Tian, Leroy Hood, Taranjit S Gujral, and Raymond S Yeung
Organotypic Models for Functional Drug Testing of Human Cancers, Yu Ling Huang, Lindsay K. Dickerson, Heidi Kenerson, Xiuyun Jiang, Venu Pillarisetty, Qiang Tian, Leroy Hood, Taranjit S. Gujral, and Raymond S. Yeung
Pan-cancer associations of B7-H3 (CD276) transcriptioinal expression across human malignancies. ASCO, Abst:2624, 6/2023., J Hwang, Dave Hoon, and See full list of authors in comments
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases., Gino K In, Jennifer R Ribeiro, Jun Yin, Joanne Xiu, Matias A Bustos, Fumito Ito, Frances Chow, Gabriel Zada, Lindsay Hwang, April K S Salama, Soo J Park, Justin C Moser, Sourat Darabi, Evidio Domingo-Musibay, Maria L Ascierto, Kim Margolin, Jose Lutzky, Geoffrey T Gibney, Michael B Atkins, Benjamin Izar, Dave Hoon, and Ari M VanderWalde
Detection of KRAS G12D/G12V neoepitopes expressed by cancer cell lines using LC-MS/MS, N Iwamoto, Will Redmond, Brian Piening, Bernard Fox, Eric Tran, and See full list of authors in comments
The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway., Sivan Izraely, Shlomit Ben-Menachem, Sapir Malka, Orit Sagi-Assif, Matias A Bustos, Orit Adir, Tsipi Meshel, Maharrish Chelladurai, Suyeon Ryu, Romela Irene Ramos, Metsada Pasmanik-Chor, Dave S B Hoon, and Isaac P Witz
ASO Author Reflections: Considerations for the Contralateral Breast in Patients Undergoing Oncoplastic Breast-Conserving Surgery., Katherine M Jackson and Janie Grumley
A Look at the Other Side: High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures for Patients Undergoing Oncoplastic Breast-Conserving Surgery., Katherine M Jackson, Janelle-Cheri Millen, Javier I Orozco, Stacey Stern, Crystal E Fancher, and Janie Grumley
ASO Visual Abstract: A Look at the Other Side-High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures of Patients Undergoing Oncoplastic Breast-Conserving Surgery., Katherine M Jackson, Janelle-Cheri Millen, Javier I Orozco, Stacey Stern, Crystal E Fancher, and Janie Grumley
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors., Joseph M Jacob, Solomon L Woldu, Jennifer Linehan, Craig Labbate, Kyle M Rose, Wade J Sexton, Isamu Tachibana, Hristos Kaimakliotis, Alan Nieder, Marc A Bjurlin, Mitchell Humphreys, Saum Ghodoussipor, Marcus L Quek, Brett Johnson, Michael O'Donnell, Brian H Eisner, Adam S Feldman, Katie S Murray, Surena F Matin, Yair Lotan, and Rian J Dickstein
Diagnostic Performance and Safety of, Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski, Daniel Saltzstein, Mark T Fleming, Albert Chau, Phillip Davis, Brian F Chapin, and David M Schuster
Reply by Authors., Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski, Daniel Saltzstein, Mark T Fleming, Albert Chau, Phillip Davis, Brian F Chapin, and David M Schuster
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT), Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw W Twardowski, Daniel Saltzstein, Mark T Fleming, Albert Chau, Phillip Davis, Brian F Chapin, and David M Schuster
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors., Antonio Jimeno, Joaquina Baranda, Wade T Iams, Jong Chul Park, Monica Mita, Michael S Gordon, Matthew Taylor, Neesha Dhani, Alexis D Leal, Prakash Neupane, Cathy Eng, Oladapo Yeku, Alain Mita, Justin C Moser, Marcus Butler, Scott M Loughhead, Julia Jennings, Nathan R Miselis, Rui-Ru Ji, Nitya Nair, Martin Kornacker, Ricardo F Zwirtes, Howard Bernstein, and Armon Sharei
SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16 tumors treated with cell-based vaccine, SQZ-PBMC-HPV, A Jimeno, Matthew Taylor, and See full list of authors in comments
Synergism in actions of HBV with aflatoxin in cancer development., Joshua Jin, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network., Sean J Judge, Tara Ghalambor, Michael J Cavnar, Michael E Lidsky, Ryan P Merkow, May Cho, Ismael Dominguez-Rosado, Paul J Karanicolas, Skye C Mayo, Flavio G Rocha, Ryan C Fields, Reema A Patel, Hagen F Kennecke, Bas Groot Koerkamp, Adam C Yopp, Henrik Petrowsky, Devalingham Mahalingam, Nancy Kemeny, Michael D'Angelica, and Sepideh Gholami
ASO Visual Abstract: Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy—An International Survey of the HAI Consortium Research Network, Sean J. Judge, H Kennecke, and See all authors in comments
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma., Hristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, Craig Labbate, Joseph Jacob, Katie Murray, Kyle Rose, Wade Sexton, Rian Dickstein, Jennifer M Linehan, Alan Nieder, Marc Bjurlin, Mitchell Humphreys, Saum Ghodoussipor, Marcus Quek, Michael O'Donnell, Brian H Eisner, Surena F Matin, Yair Lotan, and Adam S Feldman
Mapping inter- and intra-tumor heterogeneity in Ductal Carcinoma in situ and invasive breast cancer using integrative multi-omic profiling, H Kaplan, Carlo Bifulco, Brian Piening, and See full list of authors in comments
Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment., Henry G Kaplan, Somasundaram Subramaniam, Eric Vallières, and Todd Barnett
Hormone Receptor-Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3., Henry G Kaplan, Jeffrey R Whiteaker, Brianna Nelson, Richard G Ivey, Travis D Lorentzen, Uliana Voytovich, Lei Zhao, David J Corwin, Robert Resta, and Amanda G Paulovich
Treatment with a novel hexavalent OX40 agonist remodels the tumor microenvironment to favor anti-tumor immunity in mice, M Kasiewicz, Will Redmond, and See full list of authors in comments
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy., Saro Kasparian, Oren Wei, Ni-Chun Tsai, Joycelynne Palmer, Sumanta Pal, Yung Lyou, and Tanya Dorff
The role of dendritic cells in radiation-induced immune responses., Aanchal Preet Kaur, Alejandro F Alice, Marka R Crittenden, and Michael J. Gough
Ex vivo analysis of radiation effects on tumor infiltrating immune cells using tumor explants., Aanchal Preet Kaur, Gwen Kramer, Marka R Crittenden, and Michael Gough
Abstract 6410: Deciphering the role of MyD88 signaling pathway in regulating type I IFN-mediated responses to radiation therapy in solid tumors, Aanchal Preet Kaur, Terry R. Medler, Tiffany C. Blair, Alejandro F. Alice, Megan R. Ball, Alexa K Dowdell, Brian D. Piening, Marka R Crittenden, and Michael J. Gough
3D co-culture models demonstrate radiation-mediated activation of tumor-associated macrophages, AP Kaur, Marka R Crittenden, Michael J. Gough, and See all authors in comments
Integrative omic profiling and analyses in two pig heart to human xenotransplants, B Keating, Brian Piening, and See full list of authors in comments
Insufficient Reporting of Race and Ethnicity in Breast Cancer Clinical Trials., Grace Keegan, Angelena Crown, Charles DiMaggio, and Kathie-Ann Joseph
Diversity, Equity, and Inclusion in Clinical Trials., Grace Keegan, Angelena Crown, and Kathie-Ann Joseph
Correction: Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma: The Role of the First Postoperative Ultrasound., Jennifer Keller, Stacey Stern, Shu-Ching Chang, Rebecca Marcus, Jessica Weiss, Sean Nassoiy, Wade Christopher, Trevan Fischer, and Richard Essner
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer., Hagen F Kennecke, Rebecca Auer, May Cho, N Arvind Dasari, Cynthia Davies-Venn, Cathy Eng, Jennifer Dorth, Julio Garcia-Aguilar, Manju George, Karyn A Goodman, Lillian Kreppel, Joshua E Meyer, Jose Monzon, Leonard Saltz, Deborah Schrag, J Joshua Smith, Jason A Zell, Prajnan Das, and National Cancer Institute Rectal-Anal Task Force
Pulmonary Open, Robotic and Thoracoscopic Lobectomy (PORTaL) Study: Survival Analysis of 6,646 Cases., Michael S Kent, Matthew G Hartwig, Eric Vallières, Abbas E Abbas, Robert J Cerfolio, Mark R Dylewski, Thomas Fabian, Luis J Herrera, Kimble G Jett, Richard S Lazzaro, Bryan Meyers, Rishindra M Reddy, Michael F Reed, David C Rice, Patrick Ross, Inderpal S Sarkaria, Lana Y Schumacher, Lawrence N Spier, William B Tisol, Dennis A Wigle, and Michael Zervos
Activity of pemetrexed in pre-clinical chordoma models and humans., Santosh Kesari, Feng Wang, Tiffany Juarez, Shashaanka Ashili, C Pawan K Patro, Jose Carrillo, Minhdan Nguyen, Judy D Truong, Joan Levy, Josh Sommer, Daniel M Freed, Joanne Xiu, Yuki Takasumi, Eric Bouffet, and Jaya Mini Gill
Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma Patient., Santosh Kesari, Jeannie Williams, Erica Burbano, Meaghan Stirn, Scott Caroen, Bryan Oronsky, Tony Reid, and Chris Larson
Distant metastasis-free survival results from the randomized, phase 2 mRNA-4157-P201/KEYNOTE-942 trial., Adnan Khattak, Matthew H Taylor, and See full list of authors in comments
Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles., Hyun Ji Kim, Matthew J Rames, Florian Goncalves, C Ward Kirschbaum, Breeshey Roskams-Hieter, Elias Spiliotopoulos, Josephine Briand, Aaron Doe, Joseph Estabrook, Josiah T. Wagner, Emek Demir, Gordon Mills, and Thuy T M Ngo
Can Acupuncture be a Part of the Treatment for Breast Cancer-Related Lymphedema? A Systematic Review of the Safety and Proposed Model for Care., J K Kim, C Loo, J S Kim, C Pranskevich, and O K Gordon
FcγRIIB is an immune checkpoint limiting the activity of Treg-targeting antibodies in the tumor microenvironment., David A Knorr, Lucas Blanchard, Rom Leidner, Shawn M. Jensen, Ryan Meng, Andrew Jones, Carmen Ballesteros-Merino, Richard Bryan Bell, Maria Baez, Alessandra Marino, David Sprott, Carlo Bifulco, Brian D. Piening, Rony Dahan, Juan C Osorio, Bernard A Fox, and Jeffrey V Ravetch
SALVO: Single Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma., Lisa A Kottschade, Gregory Russell Pond, Anthony J Olszanski, Yousef Zakharia, Evidio Domingo-Musibay, Ralph J Hauke, Brendan Curti, Sarah Schober, Mohammed M Milhem, Matthew S Block, Tina Hieken, and Robert R McWilliams
Fluorescence tracking demonstrates a rapid cycle of Treg recirculation to tumor draining lymph nodes and back to tumors that is interrupted by radiation therapy, G Kramer, Michael Gough, and See full list of authors in comments
International consensus statement on allergy and rhinology: Sinonasal tumors., Edward C Kuan, Eric W Wang, Nithin D Adappa, Daniel M Beswick, Nyall R London, Shirley Y Su, Marilene B Wang, Waleed M Abuzeid, Borislav Alexiev, Jeremiah A Alt, Paolo Antognoni, Michelle Alonso-Basanta, Pete S Batra, Mihir Bhayani, Diana Bell, Manuel Bernal-Sprekelsen, Christian S Betz, Jean-Yves Blay, Benjamin S Bleier, Juliana Bonilla-Velez, Claudio Callejas, Ricardo L Carrau, Roy R Casiano, Paolo Castelnuovo, Rakesh K Chandra, Vasileios Chatzinakis, Simon B Chen, Alexander G Chiu, Garret Choby, Naweed I Chowdhury, Martin J Citardi, Marc A Cohen, Roi Dagan, Gianluca Dalfino, Iacopo Dallan, Camila Soares Dassi, John de Almeida, Angelo P Dei Tos, John M DelGaudio, Charles S Ebert, Ivan H El-Sayed, Jean Anderson Eloy, James J Evans, Christina H Fang, Nyssa F Farrell, Marco Ferrari, Nancy Fischbein, Adam Folbe, Wytske J Fokkens, Meha G Fox, Valerie J Lund, Gary L Gallia, Paul A Gardner, Mathew Geltzeiler, Christos Georgalas, Anne E Getz, Satish Govindaraj, Stacey T Gray, Jessica W Grayson, Bradley A Gross, Jordon G Grube, Ruifeng Guo, Patrick K Ha, Ashleigh A Halderman, Ehab Y Hanna, Richard J Harvey, Stephen C Hernandez, Adam L Holtzman, Claire Hopkins, Zhigang Huang, Zhenxiao Huang, Ian M Humphreys, Peter H Hwang, Alfred M Iloreta, Masaru Ishii, Michael E Ivan, Aria Jafari, David W Kennedy, Mohemmed Khan, Adam J Kimple, Todd T Kingdom, Anna Knisely, Ying-Ju Kuo, Devyani Lal, Eric D Lamarre, Ming-Ying Lan, Hien Le, Matt Lechner, Nancy Y Lee, Jivianne K Lee, Victor H Lee, Corinna G Levine, Jin-Ching Lin, Derrick T Lin, Brian C Lobo, Tran Locke, Amber U Luong, Kelly R Magliocca, Svetomir N Markovic, Gesa Matnjani, Erin L McKean, Cem Meço, William M Mendenhall, Loren Michel, Shorook Na'ara, Piero Nicolai, Daniel W Nuss, Gurston G Nyquist, Gretchen M Oakley, Kazuhiro Omura, Richard R Orlandi, Nobuyoshi Otori, Peter Papagiannopoulos, Zara M Patel, David G Pfister, Jack Phan, Alkis J Psaltis, Mindy R Rabinowitz, Murugappan Ramanathan, Ryan Rimmer, Marc R Rosen, Olabisi Sanusi, Zoukaa B Sargi, Philippe Schafhausen, Rodney J Schlosser, Ahmad R Sedaghat, Brent A Senior, Raj Shrivastava, Raj Sindwani, Timothy L Smith, Kristine A Smith, Carl H Snyderman, C Arturo Solares, Satyan B Sreenath, Aldo Stamm, Katharina Stölzel, Baran Sumer, Pavol Surda, Bobby A Tajudeen, Lester D R Thompson, Brian D Thorp, Charles C L Tong, Raymond K Tsang, Justin H Turner, Mario Turri-Zanoni, Aaron M Udager, Thibaut van Zele, Kyle VanKoevering, Kevin C Welch, Sarah K Wise, Ian J Witterick, Tae-Bin Won, Stephanie N Wong, Bradford A Woodworth, Peter-John Wormald, William C Yao, Chien-Fu Yeh, Bing Zhou, and James N Palmer
Diagnostics of Thyroid Cancer Using Machine Learning and Metabolomics., Alyssa Kuang, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer., Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien, Anne M Wallace, Andres Forero-Torres, Lajos Pusztai, Erin D Ellis, Kathy S Albain, Anne H Blaes, Barbara B Haley, Judy C Boughey, Anthony D Elias, Amy S Clark, Claudine J Isaacs, Rita Nanda, Hyo S Han, Rachel L Yung, Debasish Tripathy, Kristen K Edmiston, Rebecca K Viscusi, Donald W Northfelt, Qamar J Khan, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruixiao Lu, William Fraser Symmans, Douglas Yee, Angela M DeMichele, Laura J van 't Veer, Laura J Esserman, and Olufunmilayo I Olopade
Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma., Craig Labbate, Solomon Woldu, Katie Murray, Kyle Rose, Wade Sexton, Isamu Tachibana, Hristov Kaimakliotis, Joseph Jacob, Rian Dickstein, Jennifer Linehan, Alan Nieder, Marc Bjurlin, Mitchell Humphreys, Saum Ghodoussipor, Marcus Quek, Michael O'Donnell, Brian Eisner, Adam Feldman, Yair Lotan, and Surena F Matin
Uterine Inflammatory Myofibroblastic Tumors: Proposed Risk Stratification Model Using Integrated Clinicopathologic and Molecular Analysis., Nicholas R Ladwig, Gregory R Bean, Melike Pekmezci, John Boscardin, Nancy M Joseph, Nicole Therrien, Ankur R Sangoi, Brian D. Piening, Venkatesh Rajamanickam, Matthew Galvin, Brady Bernard, Charles Zaloudek, Joseph T Rabban, Karuna Garg, and Sarah E Umetsu
Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel., Primo N Lara, Edward Mayerson, Erik Gertz, Catherine Tangen, Amir Goldkorn, Marta van Loan, Maha Hussain, Shilpa Gupta, Jingsong Zhang, Mamta Parikh, Przemyslaw Twardowski, David I Quinn, Michael LeBlanc, Nicholas J Vogelzang, Ian Thompson, and Neeraj Agarwal
Updates in Cardio-Oncology, ME Layoun
Regulation of human and mouse bystander T cell activation responses by PD-1., Catherine T Le, Logan V Vick, Craig Collins, Cordelia Dunai, Michael K Sheng, Lam T Khuat, Isabel Barao, Sean J Judge, Ethan G Aguilar, Brendan Curti, Maneesh Dave, Dan L Longo, Bruce R Blazar, Robert J Canter, Arta M Monjazeb, and William J Murphy
Interprofessional Collaboration Optimizes Oncology Navigation Efficiency and Value, Lauri Ledbeter, Whitney Daws, Rebekah Hart, and Lindsay Shimizu
Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial., Jay M Lee, Eric Vallieres, Beiying Ding, Ann Johnson, Jan Bhagwakar, Sanam Rashidi, Qian Cindy Zhu, Barbara J Gitlitz, Benny Weksler, Kimberly E Costas, and Nasser Altorki
TCR engagers VS CAR-T, Rom Leidner
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors., Rom Leidner, Kevin Conlon, Douglas G McNeel, Andrea Wang-Gillam, Sumati Gupta, Robert Wesolowski, Monica Chaudhari, Nadia Hassounah, Jong Bong Lee, Lang Ho Lee, Jessica A O'Keeffe, Nancy Lewis, George N Pavlakis, and John A Thompson
Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study, N Leighl, Rachel Sanborn, and See all authors in comments
Radiofrequency Ablation Provides Rapid and Durable Pain Relief for the Palliative Treatment of Lytic Bone Metastases Independent of Radiation Therapy: Final Results from the OsteoCool Tumor Ablation Post-Market Study., Jason Levy, Elizabeth David, Thomas Hopkins, Jonathan Morris, Nam D Tran, Hamed Farid, Francesco Massari, William G O'Connell, Alexander Vogel, Afshin Gangi, Peter Sunenshine, Robert Dixon, Nicolas Von der Höh, and Sandeep Bagla
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat., Akeem R Lewis, Grace M Choong, Elizabeth Cathcart-Rake, Narjust Florez, Urshila Durani, Siddhartha Yadav, Harry Fuentes, Karl Sorensen, Daniel S Childs, Antoine Saliba, Jonas Paludo, and Timothy J Hobday
Phase 1/1b study of PRGN-3005 autologous UltraCAR-T cells manufactured overnight for infusion next day to advanced stage platinum resistant ovarian cancer patients, JB Liao, SE Stanton, and See all authors in comments
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial., Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim, Fabio M Iwamoto, David D Tran, George Ansstas, Charles Cobbs, Jason A Heth, Michael E Salacz, Stacy D'Andre, Robert D Aiken, Yaron A Moshel, Joo Y Nam, Clement P Pillainayagam, Stephanie A Wagner, Kevin A Walter, Rekha Chaudhary, Samuel A Goldlust, Ian Y Lee, Daniela A Bota, Heinrich Elinzano, Jai Grewal, Kevin Lillehei, Tom Mikkelsen, Tobias Walbert, Steven Abram, Andrew J Brenner, Matthew G Ewend, Simon Khagi, Darren S Lovick, Jana Portnow, Lyndon Kim, William G Loudon, Nina L Martinez, Reid C Thompson, David E Avigan, Karen L Fink, Francois J Geoffroy, Pierre Giglio, Oleg Gligich, Dietmar Krex, Scott M Lindhorst, Jose Lutzky, Hans-Jörg Meisel, Minou Nadji-Ohl, Lhagva Sanchin, Andrew Sloan, Lynne P Taylor, Julian K Wu, Erin M Dunbar, Arnold B Etame, Santosh Kesari, David Mathieu, David E Piccioni, David S Baskin, Michel Lacroix, Sven-Axel May, Pamela Z New, Timothy J Pluard, Steven A Toms, Victor Tse, Scott Peak, John L Villano, James D Battiste, Paul J Mulholland, Michael L Pearlman, Kevin Petrecca, Michael Schulder, Robert M Prins, Alton L Boynton, and Marnix L Bosch
Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes., Jennifer M Linehan, Josh Gottlieb, Solomon L Woldu, Craig Labbate, Kyle Rose, Wade Sexton, Hristos Kaimakliotis, Joseph Jacob, Rian Dickstein, Alan Nieder, Marc Bjurlin, Mitchell Humphreys, Saum Ghodoussipor, Marcus Quek, Michael O'Donnell, Brian H Eisner, Adam S Feldman, Surena F Matin, Yair Lotan, and Katie S Murray
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]., Jennifer M Linehan, Josh Gottlieb, Solomon L Woldu, Craig Labbate, Kyle Rose, Wade Sexton, Hristos Kaimakliotis, Joseph Jacob, Rian Dickstein, Alan Nieder, Marc Bjurlin, Mitchell Humphreys, Saum Ghodoussipour, Marcus Quek, Michael O'Donnell, Brian H Eisner, Adam S Feldman, Surena F Matin, Yair Lotan, and Katie S Murray
Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS., Andy Liu, Huda Alalami, Xuemo Fan, Chirag Patil, Jaya M Gill, Santosh Kesari, and Jethro Hu
Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors., Pere Llinàs-Arias, Miquel Ensenyat-Mendez, Sandra Íñiguez-Muñoz, Javier I Orozco, Betsy Valdez, Matthew P Salomon, Chikako Matsuba, Maria Solivellas-Pieras, Andrés F Bedoya-López, Borja Sesé, Anja Mezger, Mattias Ormestad, Fernando Unzueta, Siri H Strand, Alexander D Boiko, E Shelley Hwang, Javier Cortés, Maggie L DiNome, Manel Esteller, Mathieu Lupien, and Diego M Marzese
3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer., Pere Llinàs-Arias, Miquel Ensenyat-Méndez, Javier I Orozco, Sandra Íñiguez-Muñoz, Betsy Valdez, Chuan Wang, Anja Mezger, Eunkyoung Choi, Yan Zhou Tran, Liqun Yao, Franziska Bonath, Remi-André Olsen, Mattias Ormestad, Manel Esteller, Mathieu Lupien, and Diego M Marzese
An Analysis of Patient Characteristics Associated with Myelosuppression Among Small Cell Lung Cancer (SCLC) Patients Treated in US Community Cancer Care Practices, L Lopez-Gonzalez, Rachel E Sanborn, Roshanthi Weerasinghe, Amy S. Parrish, and See full list of authors in comments
SGN-B6A, an integrin beta-6 (ITGB6)-targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors: Updated results from a phase 1 study (SGNB6A-001), JS Lopez, Rachel Sanborn, and See all authors in comments
Long-term efficacy, safety, and predictors of response to amivantamab among patients with post-platinum EGFR Ex20ins-mutated advanced NSCLC, PG Lopez, Rachel E Sanborn, and See full list of authors in comments
Long-term efficacy, safety, and predictors of response to amivantamab among patients with post-platinum EGFR Ex20ins-mutated advanced NSCLC, PG Lopez, RE Sanborn, and See full list of authors in comments
Feasibility of circulating tumor DNA (ctDNA) to guide organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II CCTG CO.28 trial, Jonathan M. Loree, Hagen F Kennecke, and See full list of authors in comments
ACR-ARS Practice Parameter for Radiation Oncology., Simon Lo, Samuel Chao, Eleanor Harris, Jonathan Knisely, Join Y Luh, Pranshu Mohindra, Tony S Quang, Jason Ye, William Small, and Naomi R Schechter
Lorigerlimab, a bispecific PD-1×CTLA-4 DART molecule in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A phase 1 expansion (exp) cohort., Jason J. Luke, Rachel E Sanborn, and See full list of authors in comments
CT251 / 14 - Phase 1/2 study of HST-1011, an oral CBL-B inhibitor, alone and in combination with anti-PD1 in patients with advanced solid tumors, J Luke, Rachel E Sanborn, and See full list of authors in comments
